HOOKIPA Pharma Inc. (HOOK)
OTCMKTS · Delayed Price · Currency is USD
1.150
+0.010 (0.88%)
Inactive · Last trade price on Jun 2, 2026

HOOKIPA Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
9.3543.9520.1314.2518.4519.58
Revenue Growth
-82.54%118.32%41.27%-22.76%-5.80%63.99%
Gross Profit
-50.47-23.19-64.95-52.97-62.5-33.55
Operating Income
-74.9-44.79-84.93-73.16-81.67-53.29
Net Income
-73.31-43.5-81.58-64.92-75.67-44.08
Earnings Per Share
-5.85-3.47-8.63-9.91-23.04-16.93
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
40.2839.68117.1112.4965.92142.74
Total Debt
0.60.886.566.510.6310.77
Net Cash (Debt)
39.6838.81110.54105.9955.3131.98
Net Cash Growth
-54.22%-64.89%4.29%91.67%-58.10%30.93%
Net Cash Per Share
3.173.1011.6916.1816.8450.68

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-52.77-76.98-57.52-20-66.02-39.34
Capital Expenditures
-0.1-0.19-4.16-5.02-12.58-2.37
Free Cash Flow
-52.87-77.17-61.68-25.01-78.6-41.71
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingMar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
--52.76%----171.31%
Operating Margin
-801.02%-101.91%-421.92%-513.40%-442.72%-272.08%
Pretax Margin
-785.15%-99.23%-403.46%-453.96%-410.15%-225.09%
Profit Margin
-784.01%-98.99%-405.29%-455.58%-410.15%-225.09%
FCF Margin
-565.37%-175.61%-306.44%-175.55%-426.05%-212.98%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
1.570.575.054.114.1616.46